106 related articles for article (PubMed ID: 3475205)
21. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse.
Lauer S; Piaskowski V; Camitta B; Casper J
Leuk Res; 1982; 6(6):769-74. PubMed ID: 6961270
[TBL] [Abstract][Full Text] [Related]
23. Use of specific antisera against leukemia-associated antigens in the diagnosis of childhood acute lymphoblastic leukemia.
Netzel B; Rodt H; Thiel E; Haas RJ; Thierfelder S
Acta Haematol; 1979; 61(4):177-83. PubMed ID: 108896
[TBL] [Abstract][Full Text] [Related]
24. Some aspects of the lymphocytes kinetics during treatment of childhood acute lymphoblastic leukemia.
Debiec-Rychter M
Oncology; 1983; 40(5):315-20. PubMed ID: 6194486
[TBL] [Abstract][Full Text] [Related]
25. Diminished lymphocyte and granulocyte gamma-glutamyltranspeptidase activity in acute lymphocytic leukemia and response to chemotherapy.
Russo SA; Harris MB; Greengard O
Am J Hematol; 1987 Sep; 26(1):67-75. PubMed ID: 2888307
[TBL] [Abstract][Full Text] [Related]
26. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
27. Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome in childhood acute lymphoblastic leukaemia.
Murphy SB; Borella L; Sen L; Mauer A
Br J Haematol; 1975 Sep; 31(1):95-101. PubMed ID: 764854
[TBL] [Abstract][Full Text] [Related]
28. Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Ludwig WD; van Dongen JJ; Thiel E; Teichmann JV; Hofmann J; Riehm H
Onkologie; 1990 Jun; 13(3):166-74. PubMed ID: 2204002
[TBL] [Abstract][Full Text] [Related]
29. Bone-marrow relapse in acute lymphoblastic leukaemia in childhood.
Cornbleet MA; Chessells JM
Br Med J; 1978 Jul; 2(6130):104-6. PubMed ID: 276410
[TBL] [Abstract][Full Text] [Related]
30. Autologous and allogeneic typing of human leukemia cells: definition of surface antigens restricted to lymphocytic leukemia cells.
Naito K; Yamaguchi H; Horibe K; Shiku H; Takahashi T; Suzuki S; Yamada K
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2341-5. PubMed ID: 6572980
[TBL] [Abstract][Full Text] [Related]
31. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
[TBL] [Abstract][Full Text] [Related]
32. Subset derivation of T-cell acute lymphoblastic leukemia in man.
Reinherz EL; Nadler LM; Sallan SE; Schlossman SF
J Clin Invest; 1979 Aug; 64(2):392-7. PubMed ID: 313405
[TBL] [Abstract][Full Text] [Related]
33. Burkitt's lymphoma presenting as acute leukemia (Burkitt's lymphoma cell leukemia): report of two cases in Israel.
Prokocimer M; Matzner Y; Ben-Bassat H; Polliack A
Cancer; 1980 Jun; 45(11):2884-9. PubMed ID: 6929723
[TBL] [Abstract][Full Text] [Related]
34. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
36. Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy.
van Laarhoven JP; Spierenburg GT; Bakkeren JA; Schouten TJ; De Bruyn CH; Geerts SJ; Schretlen ED
Leuk Res; 1983; 7(3):407-20. PubMed ID: 6310274
[TBL] [Abstract][Full Text] [Related]
37. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
[TBL] [Abstract][Full Text] [Related]
38. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
39. Studies of T, B, and null lymphocytes during the course of acute lymphocytic leukemia.
Hann HW; London WT; Evans AE
Cancer; 1977 Apr; 39(4):1489-94. PubMed ID: 300648
[TBL] [Abstract][Full Text] [Related]
40. [The differentiation of human peripheral blood lymphocytes by immunological methods. III. Results in acute lymphoblastic leukemia (author's transl)].
Pathouli C; Michlmayr G; Huber C; Kurz R; Haas H; Resch R; Falkensammer M; Abbrederis K; Huber H; Braunsteiner H
Klin Wochenschr; 1977 Jul; 55(13):629-34. PubMed ID: 302368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
